EPISODE · Jun 4, 2026 · 1 MIN
2026 ASCO: Navigating the Era of Adoptive Cellular Therapy and Finite-Duration Regimens in Advanced Malignancies
from TheBrief.Health · host TheBrief.Health
A fundamental shift is underway in advanced oncology: the move from continuous, 'treat-to-progression' regimens to high-efficacy, finite-duration protocols. This evolution redefines long-term patient management and offers new potential for durable, treatment-free responses.
What this episode covers
A fundamental shift is underway in advanced oncology: the move from continuous, 'treat-to-progression' regimens to high-efficacy, finite-duration protocols. This evolution redefines long-term patient management and offers new potential for durable, treatment-free responses.
NOW PLAYING
2026 ASCO: Navigating the Era of Adoptive Cellular Therapy and Finite-Duration Regimens in Advanced Malignancies
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m